Skip to content

Usage of the Home Macular Perimeter (HMP)

Usage of the Home Macular Perimeter (HMP) in Intermediate Age Related Macular Degeneration Patients Pilot Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00596388
Acronym
HMP
Enrollment
20
Registered
2008-01-17
Start date
2008-03-31
Completion date
2013-03-31
Last updated
2013-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Age Related Macular Degeneration

Keywords

HMP, AMD, CNV, PHP, HPHP

Brief summary

Demonstrate the ability of the current interactive tutorial and 1-800 support to teach an AMD patient to use the HMP device.

Detailed description

The pilot study purpose is to demonstrate that the tutorial which is part of the device software, is giving sufficient training for the intended users.

Interventions

None listed

Sponsors

Notal Vision Ltd.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Capable and willing to sign a consent form and participate in the study * Subjects diagnosed as intermediate AMD in at least one eye * Age \>50 years * VA with habitual correction \>20/60 in the study eye * Ability to speak, read and understand instructions in Hebrew * Familiar with computer usage

Exclusion criteria

* Evidence of macular disease other than AMD or glaucoma in the study eye * Presence of any significant media opacity that precludes a clear view of the macular area as identified in the study eye by biomicroscopy, CFP. * Any non-macular related ocular surgery performed within 3 months prior to study entry in the target eye * Participation in another study with the exclusion of AREDS study * Patients diagnosed with geographic atrophy (GA)

Design outcomes

Primary

MeasureTime frame
Proportion of subjects who manage to use the device as in a daily testing6 month

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026